Literature DB >> 24326256

Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration.

Xiaowu Gu1, Steven J Fliesler2, You-Yang Zhao3, William B Stallcup4, Alex W Cohen5, Michael H Elliott6.   

Abstract

Blood-retinal barrier (BRB) breakdown and related vascular changes are implicated in several ocular diseases. The molecules and mechanisms regulating BRB integrity and pathophysiology are not fully elucidated. Caveolin-1 (Cav-1) ablation results in loss of caveolae and microvascular pathologies, but the role of Cav-1 in the retina is largely unknown. We examined BRB integrity and vasculature in Cav-1 knockout mice and found a significant increase in BRB permeability, compared with wild-type controls, with branch veins being frequent sites of breakdown. Vascular hyperpermeability occurred without apparent alteration in junctional proteins. Such hyperpermeability was not rescued by inhibiting eNOS activity. Veins of Cav-1 knockout retinas exhibited additional pathological features, including i) eNOS-independent enlargement, ii) altered expression of mural cell markers (eg, down-regulation of NG2 and up-regulation of αSMA), and iii) dramatic alterations in mural cell phenotype near the optic nerve head. We observed a significant NO-dependent increase in retinal artery diameter in Cav-1 knockout mice, suggesting that Cav-1 plays a role in autoregulation of resistance vessels in the retina. These findings implicate Cav-1 in maintaining BRB integrity in retinal vasculature and suggest a previously undefined role in the retinal venous system and associated mural cells. Our results are relevant to clinically significant retinal disorders with vascular pathologies, including diabetic retinopathy, uveoretinitis, and primary open-angle glaucoma.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24326256      PMCID: PMC3906491          DOI: 10.1016/j.ajpath.2013.10.022

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  77 in total

1.  Co-regulation of transcellular and paracellular leak across microvascular endothelium by dynamin and Rac.

Authors:  Susan M Armstrong; Vahid Khajoee; Changsen Wang; Tieling Wang; Jayesh Tigdi; Jun Yin; Wolfgang M Kuebler; Mark Gillrie; Shevaun P Davis; May Ho; Warren L Lee
Journal:  Am J Pathol       Date:  2011-12-25       Impact factor: 4.307

Review 2.  Diabetic retinopathy.

Authors:  David A Antonetti; Ronald Klein; Thomas W Gardner
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

3.  Retinal vein pulsation is in phase with intracranial pressure and not intraocular pressure.

Authors:  William H Morgan; Christopher R P Lind; Samuel Kain; Naeem Fatehee; Arul Bala; Dao-Yi Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-10       Impact factor: 4.799

4.  Leukemia inhibitory factor coordinates the down-regulation of the visual cycle in the retina and retinal-pigmented epithelium.

Authors:  Ana J Chucair-Elliott; Michael H Elliott; Jiangang Wang; Gennadiy P Moiseyev; Jian-Xing Ma; Luis E Politi; Nora P Rotstein; Shizuo Akira; Satoshi Uematsu; John D Ash
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 5.  A brief history of anti-VEGF for the treatment of ocular angiogenesis.

Authors:  Leo A Kim; Patricia A D'Amore
Journal:  Am J Pathol       Date:  2012-06-29       Impact factor: 4.307

6.  Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment.

Authors:  Xiaoman Li; Mark E McClellan; Masaki Tanito; Philippe Garteiser; Rheal Towner; David Bissig; Bruce A Berkowitz; Steven J Fliesler; Michael L Woodruff; Gordon L Fain; David G Birch; M Suhaib Khan; John D Ash; Michael H Elliott
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

7.  Targeted deletion of Vegfa in adult mice induces vision loss.

Authors:  Toshihide Kurihara; Peter D Westenskow; Stephen Bravo; Edith Aguilar; Martin Friedlander
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

8.  Expression and role of VEGF--a in the ciliary body.

Authors:  Knatokie M Ford; Magali Saint-Geniez; Tony E Walshe; Patricia A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-07       Impact factor: 4.799

9.  Caveolin-1 deficiency induces spontaneous endothelial-to-mesenchymal transition in murine pulmonary endothelial cells in vitro.

Authors:  Zhaodong Li; Peter J Wermuth; Bryan S Benn; Michael P Lisanti; Sergio A Jimenez
Journal:  Am J Pathol       Date:  2012-11-27       Impact factor: 4.307

10.  Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo.

Authors:  Tomoaki Murakami; Tiffany Frey; Chengmao Lin; David A Antonetti
Journal:  Diabetes       Date:  2012-03-20       Impact factor: 9.461

View more
  19 in total

Review 1.  Genes, pathways, and animal models in primary open-angle glaucoma.

Authors:  A I Iglesias; H Springelkamp; W D Ramdas; C C W Klaver; R Willemsen; C M van Duijn
Journal:  Eye (Lond)       Date:  2015-08-28       Impact factor: 3.775

2.  Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation.

Authors:  Xiaoman Li; Xiaowu Gu; Timothy M Boyce; Min Zheng; Alaina M Reagan; Hui Qi; Nawajes Mandal; Alex W Cohen; Michelle C Callegan; Daniel J J Carr; Michael H Elliott
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

3.  Exome array analysis identifies CAV1/CAV2 as a susceptibility locus for intraocular pressure.

Authors:  Fei Chen; Alison P Klein; Barbara E K Klein; Kristine E Lee; Barbara Truitt; Ronald Klein; Sudha K Iyengar; Priya Duggal
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-18       Impact factor: 4.799

4.  Age-related focal loss of contractile vascular smooth muscle cells in retinal arterioles is accelerated by caveolin-1 deficiency.

Authors:  Alaina M Reagan; Xiaowu Gu; Sijalu Paudel; Nicole M Ashpole; Michelle Zalles; William E Sonntag; Zoltan Ungvari; Anna Csiszar; Laura Otalora; Willard M Freeman; Michael B Stout; Michael H Elliott
Journal:  Neurobiol Aging       Date:  2018-07-10       Impact factor: 4.673

Review 5.  Caveolins and caveolae in ocular physiology and pathophysiology.

Authors:  Xiaowu Gu; Alaina M Reagan; Mark E McClellan; Michael H Elliott
Journal:  Prog Retin Eye Res       Date:  2016-09-21       Impact factor: 21.198

Review 6.  Caveolins as Regulators of Stress Adaptation.

Authors:  Jan M Schilling; Brian P Head; Hemal H Patel
Journal:  Mol Pharmacol       Date:  2018-01-22       Impact factor: 4.436

7.  Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation.

Authors:  Mojdeh Abbasi; Vivek K Gupta; Nitin Chitranshi; Veer B Gupta; Mehdi Mirzaei; Yogita Dheer; Linda Garthwaite; Thiri Zaw; Robert G Parton; Yuyi You; Stuart L Graham
Journal:  Mol Neurobiol       Date:  2020-06-23       Impact factor: 5.590

8.  Regulation of Phagolysosomal Digestion by Caveolin-1 of the Retinal Pigment Epithelium Is Essential for Vision.

Authors:  Saumil Sethna; Tess Chamakkala; Xiaowu Gu; Timothy C Thompson; Guangwen Cao; Michael H Elliott; Silvia C Finnemann
Journal:  J Biol Chem       Date:  2016-01-26       Impact factor: 5.157

9.  Comments to the Editor concerning the paper entitled "The microbiome and ophthalmic disease" by Baim et al.

Authors:  Michael Doulberis; Stergios A Polyzos; Apostolis Papaefthymiou; Panagiotis Katsinelos; Jannis Kountouras
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-17

10.  Targeting the raft-associated Akt signaling in hepatocellular carcinoma.

Authors:  Yuan Liu; Ji-Yun Lv; Jian-Fei Shi; Mei Yang; Shu-Hong Liu; Zhi-Wei Li; Hong-Bo Wang; Shao-Geng Zhang; Zhen-Wen Liu; Jin-Biao Ding; Dong-Ping Xu; Jing-Min Zhao
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.